固定式氧浓缩器内置呼吸速率监测仪:对间质性肺疾病和慢性阻塞性肺疾病疗效的临床验证。

IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Internal Medicine Pub Date : 2025-09-15 Epub Date: 2025-03-08 DOI:10.2169/internalmedicine.5012-24
Satoshi Hamada, Tomohiro Handa, Kimihiko Murase, Naoya Tanabe, Yoshinari Nakatsuka, Kohei Ikezoe, Hironobu Sunadome, Susumu Sato, Atsuyasu Sato, Toyohiro Hirai
{"title":"固定式氧浓缩器内置呼吸速率监测仪:对间质性肺疾病和慢性阻塞性肺疾病疗效的临床验证。","authors":"Satoshi Hamada, Tomohiro Handa, Kimihiko Murase, Naoya Tanabe, Yoshinari Nakatsuka, Kohei Ikezoe, Hironobu Sunadome, Susumu Sato, Atsuyasu Sato, Toyohiro Hirai","doi":"10.2169/internalmedicine.5012-24","DOIUrl":null,"url":null,"abstract":"<p><p>Objective The respiratory rate (RR) can be monitored continuously using a HiSanso<sup>®</sup>i, a stationary oxygen concentrator with a built-in respiratory sensor. To examine the efficacy of this device, we compared its performance with that of polysomnography in inpatient settings and the home sleep apnea test (HSAT) in residential settings for patients with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). Methods The oxygen flow rate was set at 1, 3, and 5 L/min in inpatient settings and 1-3 L/min (conditions similar to the home surroundings) in residential settings. Intraclass correlation coefficients (ICCs) (2,1) were calculated to determine the agreement between the RR measured with the HiSanso<sup>®</sup>i and that measured with polysomnography or the HSAT. The minimum acceptable reliability level is 0.7. Results In total, 14 (10 with ILD and 4 with COPD) and 5 (all with ILD) patients were assessed in inpatient and residential settings, respectively. In inpatient settings, the detection rate of patients' respiration measured with the HiSanso<sup>®</sup>i was 77.0% and 73.3% in patients with ILD and COPD, respectively. At oxygen flow rates of 1, 3, and 5 L/min, the ICCs (2,1) were 0.91, 0.85, and 0.91, respectively, for patients with ILD and 0.96, 0.90, and 0.74, respectively, for patients with COPD. In residential settings, the detection rate of patients' respiration measured with the HiSanso<sup>®</sup>i was 86.6%, and the ICC (2,1) was 0.97. Conclusion The HiSanso<sup>®</sup>i accurately monitored the RR without any additional devices, independent of oxygen flow rates or disease status.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"2708-2715"},"PeriodicalIF":1.1000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stationary Oxygen Concentrator with Built-in Respiratory Rate Monitor: Clinical Validation of Its Efficacy in Patients with Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease.\",\"authors\":\"Satoshi Hamada, Tomohiro Handa, Kimihiko Murase, Naoya Tanabe, Yoshinari Nakatsuka, Kohei Ikezoe, Hironobu Sunadome, Susumu Sato, Atsuyasu Sato, Toyohiro Hirai\",\"doi\":\"10.2169/internalmedicine.5012-24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Objective The respiratory rate (RR) can be monitored continuously using a HiSanso<sup>®</sup>i, a stationary oxygen concentrator with a built-in respiratory sensor. To examine the efficacy of this device, we compared its performance with that of polysomnography in inpatient settings and the home sleep apnea test (HSAT) in residential settings for patients with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). Methods The oxygen flow rate was set at 1, 3, and 5 L/min in inpatient settings and 1-3 L/min (conditions similar to the home surroundings) in residential settings. Intraclass correlation coefficients (ICCs) (2,1) were calculated to determine the agreement between the RR measured with the HiSanso<sup>®</sup>i and that measured with polysomnography or the HSAT. The minimum acceptable reliability level is 0.7. Results In total, 14 (10 with ILD and 4 with COPD) and 5 (all with ILD) patients were assessed in inpatient and residential settings, respectively. In inpatient settings, the detection rate of patients' respiration measured with the HiSanso<sup>®</sup>i was 77.0% and 73.3% in patients with ILD and COPD, respectively. At oxygen flow rates of 1, 3, and 5 L/min, the ICCs (2,1) were 0.91, 0.85, and 0.91, respectively, for patients with ILD and 0.96, 0.90, and 0.74, respectively, for patients with COPD. In residential settings, the detection rate of patients' respiration measured with the HiSanso<sup>®</sup>i was 86.6%, and the ICC (2,1) was 0.97. Conclusion The HiSanso<sup>®</sup>i accurately monitored the RR without any additional devices, independent of oxygen flow rates or disease status.</p>\",\"PeriodicalId\":13719,\"journal\":{\"name\":\"Internal Medicine\",\"volume\":\" \",\"pages\":\"2708-2715\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2169/internalmedicine.5012-24\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2169/internalmedicine.5012-24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目的HiSanso®i固定式氧浓缩器内置呼吸传感器,可实现呼吸速率(RR)的连续监测。为了检验该设备的有效性,我们将其与住院多导睡眠图和住院间质性肺疾病(ILD)和慢性阻塞性肺疾病(COPD)患者的家庭睡眠呼吸暂停测试(HSAT)的性能进行了比较。方法住院部设氧流量为1、3、5 L/min,住院部设氧流量为1 ~ 3 L/min(与家庭环境相似)。计算类内相关系数(ICCs)(2,1),以确定HiSanso®i测量的RR与多导睡眠图或HSAT测量的RR之间的一致性。最低可接受的可靠性等级为0.7。结果共有14例(10例ILD, 4例COPD)和5例(均为ILD)患者在住院和住院环境中接受了评估。在住院环境中,HiSanso®i测量的患者呼吸检出率在ILD和COPD患者中分别为77.0%和73.3%。在氧流量为1,3和5l /min时,ILD患者的ICCs(2,1)分别为0.91、0.85和0.91,COPD患者的ICCs(2,1)分别为0.96、0.90和0.74。在居住环境中,HiSanso®i测量的患者呼吸检出率为86.6%,ICC(2,1)为0.97。结论:HiSanso®无需任何额外装置即可准确监测RR,不受氧流量或疾病状态的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Stationary Oxygen Concentrator with Built-in Respiratory Rate Monitor: Clinical Validation of Its Efficacy in Patients with Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease.

Objective The respiratory rate (RR) can be monitored continuously using a HiSanso®i, a stationary oxygen concentrator with a built-in respiratory sensor. To examine the efficacy of this device, we compared its performance with that of polysomnography in inpatient settings and the home sleep apnea test (HSAT) in residential settings for patients with interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). Methods The oxygen flow rate was set at 1, 3, and 5 L/min in inpatient settings and 1-3 L/min (conditions similar to the home surroundings) in residential settings. Intraclass correlation coefficients (ICCs) (2,1) were calculated to determine the agreement between the RR measured with the HiSanso®i and that measured with polysomnography or the HSAT. The minimum acceptable reliability level is 0.7. Results In total, 14 (10 with ILD and 4 with COPD) and 5 (all with ILD) patients were assessed in inpatient and residential settings, respectively. In inpatient settings, the detection rate of patients' respiration measured with the HiSanso®i was 77.0% and 73.3% in patients with ILD and COPD, respectively. At oxygen flow rates of 1, 3, and 5 L/min, the ICCs (2,1) were 0.91, 0.85, and 0.91, respectively, for patients with ILD and 0.96, 0.90, and 0.74, respectively, for patients with COPD. In residential settings, the detection rate of patients' respiration measured with the HiSanso®i was 86.6%, and the ICC (2,1) was 0.97. Conclusion The HiSanso®i accurately monitored the RR without any additional devices, independent of oxygen flow rates or disease status.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Internal Medicine
Internal Medicine 医学-医学:内科
CiteScore
1.90
自引率
8.30%
发文量
0
审稿时长
2.2 months
期刊介绍: Internal Medicine is an open-access online only journal published monthly by the Japanese Society of Internal Medicine. Articles must be prepared in accordance with "The Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see Annals of Internal Medicine 108: 258-265, 1988), must be contributed solely to the Internal Medicine, and become the property of the Japanese Society of Internal Medicine. Statements contained therein are the responsibility of the author(s). The Society reserves copyright and renewal on all published material and such material may not be reproduced in any form without the written permission of the Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信